Open original FDA record ↗Recall record
- FDA identifier
- Z-2006-2020
- Company in FDA record
- Ra Medical Systems, Inc.
- FDA record creation date
- May 14, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The firm has become aware there is a potential problem with its DABRA catheters resulting in higher catheter calibration failure rate due to the product shelf life is currently less than the labeled shelf life.
Source facts
- Action
- On 9/27/19, the firm sent a "Medical Device Recall" letter to its customers via first class mail and emailed to inform them they are issuing a voluntary recall of DABRA Catheters manufactured within the time period specified below. Copies of letters were provided to Ra Medical Systems' representatives, who will visit current customers. The reason for the recall is that data collected through customer feedback and field case reporting, corroborated by internal testing, suggest that the product shelf life is currently less than the labeled shelf life, which has resulted in a higher catheter calibration failure rate. The product impacted is the DABRA Catheter manufactured from 9/24/18 - 8/26/19. The firm stated that failure to calibrate does not pose a safety risk to patients or users. Ra Medical is not aware of any reports of injury or harm related to this issue, nor is there any safety concerns for patients that have been successfully treated using products defined within this recall. The firm is instructing customer to complete recall acknowledgement form that indicates the quantity of product they have. When the form is returned to Ra Medical, we will send the customer return packaging and a shipping label for them to return the recalled product to our facility. Ra Medical Systems representatives will continue to contact customers until all products are returned, or verified no longer at the customers' sites. Each returned product will have an RMA number assigned per our procedure. It will be tagged and stored in a quarantined area. The firm will contact the customers by phone, email or mail to ensure receipt and/or compliance. Should you have any questions or need further assistance please feel free to contact Ra Medical at (442) 325-5044
- Initiated
- 2019-09-19
- Root cause
- Under Investigation by firm
- Terminated
- 2023-07-31
- Distribution
- Worldwide Distribution - US Nationwide - MI, TN, CA, FL, OR, PA, AZ, AL, VA, GA, TX, ID, AR, NC, IN, SC, CT, NY, KS, LA, NV, MS, NE, MD, IL, OK, MA, WA, MO, WI, KY. OUS - Netherlands, Pakistan, United Kingdom, Italy, France
- Recall number
- Z-2006-2020
- Recall status
- Terminated
- CDRH record ID
- 180622
- FDA record created
- 2020-05-14
- Recall event number
- 85344